SimplyTest has announced the launch of SimplyTest Oral Health-IMPLANT, according to a July 22, 2025, press release from the company. This new molecular test, which is designed to detect microbial species linked to peri-implant disease and implant failure, is the latest addition to the company’s growing SimplyTest Oral Health line.
Research, including a comprehensive review published in Cureus in 2022, has demonstrated that infection is the most frequent and preventable cause of dental implant failure. The SimplyTest Implant salivary test is engineered to detect eight high-risk pathogens (ie, Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, Fusobacterium nucleatum, Fusobacterium animalis, Candida albicans, and Pseudomonas aeruginosa) that have been recognized as contributors to inflammation, tissue degradation, and systemic immune response.
“Microbial infections are a major cause of implant-related complications,” says Joel Peek, PhD, SimplyTest’s founder and scientific advisory board chair. “With SimplyTest Oral Health-IMPLANT, clinicians now have a fast, noninvasive way to identify the microbial risks before failure occurs. It's another step forward in our mission to elevate patient care through precision-based oral health solutions.”
SimplyTest Oral Health-IMPLANT, which is designed for chairside use or at-home collection, leverages a proprietary saliva preservation and analysis system. After the sample is received at the lab via a secure clinical portal, the results are delivered within 24 to 48 hours to provide clinicians with pathogen-specific insights to support diagnostic conversations and treatment planning.
“The SimplyTest Oral Health line is part of a broader effort to redefine the standard of care in dentistry and systemic healthcare by empowering providers with tools that reveal the root causes of oral and systemic conditions,” says Justin Hunt, CEO of Spectrum Health Science. “The IMPLANT test expands our platform’s reach to support preventative implant care, surgical planning and cost-efficient treatment, which are key concerns for both clinicians and care organizations. It’s a strong example of how SimplyTest equips providers with timely insights that improve patient outcomes and help reduce avoidable expenses.”
To learn more about the IMPLANT offering or to request materials, visit: https://www.simplytest.solutions.
